Activated Leukocyte Cell Adhesion Molecule (CD166); A Cancer Stem Cell Marker for Non-Small Cell Lung Cancer?

Michael Tachezy
Introduction: Recently, the activated leukocyte cell adhesion molecule (ALCAM, CD166) was identified as an inert cancer stem cell marker for non-small cell lung cancer (NSCLC). Few data exist regarding the clinical relevance of CD166 expression in NSCLC. Material and methods: Here, we evaluate the[for full text, please go to the a.m. URL]